This week, the editorial staff was assigned the task of reviewing our Homerun slides. We have so many in the archives that we had to split them up just to get them all covered.
While looking at them, one of our production editors found a great 3-slide series on SGLT-2 Inhibitors and realized that this would be a great feature for this month’s SGLT-2 special edition. Included in these slides is information about how the SGLT-1 Inhibitors might also contribute to glucose control. To help you understand how this might work, we have an article on the use of SGLT-1/SGLT-2-combination products for the treatment of type 1 diabetes.